The Glenzocimab Biosimilar Anti-GP6 Antibody is a cutting-edge product developed for researchers studying the GP6 protein, which plays a key role in platelet activation and aggregation. This antibody, produced through a bioequivalence process, is highly specific and reactive with GP6 in human samples, ensuring reliable and accurate results in experiments.The antibody is optimized for use in a variety of applications, including Western blotting and immunohistochemistry, allowing for the detection and analysis of GP6 in different cell types and tissues.
Its high affinity for the GP6 protein makes it an essential tool for studies in cardiovascular biology, hemostasis, and thrombosis research.GP6, a member of the glycoprotein VI family, is crucial for platelet function and has been implicated in various thrombotic disorders. By targeting GP6 with the biosimilar anti-GP6 antibody, researchers can gain valuable insights into the role of GP6 in thrombosis, leading to potential advancements in the treatment and prevention of cardiovascular diseases and other related conditions.
Product Name:
Glenzocimab (Anti-GP6) Biosimilar Antibody
Size:
100 ug
Product SKU:
HDBS0127
Target:
GP6
Host Species:
Humanized
Reactivity:
Human
Recommended Dilution:
Flow Cyt 1:100
Antibody Type:
Monoclonal
Buffer:
Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8% trehalose is added as protectants before lyophilization. Please see Certificate of Analysis for specific instructions.
Storage & Shipping:
Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing).Lyophilized antibodies are shipped at ambient temperature.
Common Name:
ACT-017, ACT017
Description:
Anti-GP6(glenzocimab biosimilar) mAb
Buffer:
Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8% trehalose is added as protectants before lyophilization. Please see Certificate of Analysis for specific instructions.
Format:
Powder
Applications
Flow Cyt
Antibody Isotype:
IgG1
Guarantee:
12 months from date of dispatch
Background:
Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.
